The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in-vitro CAR-T cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
| Image |  |
|---|---|
| Description | scientific article published on 28 April 2018 |
| Author/s |
author: Ugur Uslu Beatrice Schuler-Thurner |
| Publication date | July 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |